Movement Disorders

Filter Your Results




In-Focus: Movement Disorders

March 2017—Gene Panel Analysis Expedites Diagnosis of Dystonia Gene panel analysis facilitates molecular diagnosis in complex cases of dystonia, leading to a good diagnostic yield, qu…

Inhaled Levodopa Impresses in Treating Parkinson’s OFF Periods in Phase 3 Study

Friday, February 10, 2017—New phase 3 data suggests that the experimental inhaled levodopa, CVT-301 (Acorda Therapeutics), may offer significant improvement in motor function in individuals with Parkin…

On Shaky Ground: Identifying Risk Factors For Parkinson’s Disease

Jill Giordano Farmer, DO, MPH

January/February 2017—While new studies have raised interest in the possibility of identifying risk factors for Parkinson’s disease, evidence remains weak.

Alpha-Synuclein: A Therapeutic Target and Potential Biomarker in Parkinson’s Disease

Rachel Dolhun, MD

November/December 2016—The story of alpha-synuclein and Parkinson’s disease (PD) began just two decades ago, when relatively newer genetic techniques at that time identified a single mutation …

Genetic Mutation Tied to Risk of Early Parkinson’s Disease

Tuesday, November 29, 2016—Aging appears to alter how genetic factors contribute to the development of Parkinson’s disease, according to new research that has identified a gene that may incre…

Parkinson’s Disease Therapeutic Conference to Spotlight New Research and Potential Therapeutic Targets

Wednesday, October 12, 2016—The Michael J. Fox Foundation’s 10th annual Parkinson’s Disease Therapeutic Conference, set to take place on October 24 in New York City, will bring together exper…

New DBS System for Parkinson’s Disease, Essential Tremor Approved

Friday, October 07, 2016—The deep brain stimulation market will soon be expanding, as the FDA has approved St. Jude Medical’s Infinity system for the treatment Parkinson’s disease and esse…

WPC 2016: Study Elucidates the Role of Neuroinflammation in Pre-diagnosis Parkinson’s Disease

Thursday, September 22, 2016—Anti-inflammatory agents could possibly delay progression to a manifest synucleinopathy in subjects with idiopathic REM sleep behaviour disorder (IRBD), according to new findi…


Contact Info

For advertising rates and opportunities:
Wendy Terry

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.